Magnetoencephalography
Magnetoencephalography (MEG) can achieve non-invasive dynamic imaging of brain activity in sub-millisecond time scales by measuring the magnetic field generated by nerve currents on the scalp. Through the data analysis of these signals, three-dimensional images can be generated to display the formation and decomposition of the brain network in real time. With optimized paradigm design and signal extraction technology, deep brain regions such as the insula, thalamus, hippocampus, amygdala, and brainstem can be distinguished by MEG, which is widely used in neuroscience research.
MEG Working Principles
The complexity of MEG lies in the sensing technology involved and the methods required to extract relevant signal information in a wide range of experimental environments. Basically, any current will produce magnetic induction, and its strength can be measured far away from the current source, such as with a pick-up coil. The magnetic flux passing through the surface of the coil induces a current in the coil wiring material, and its amplitude is instantaneously proportional to the amplitude of the magnetic induction, and it is easy to measure. The brain imaging of MEG in the resting state is shown in Fig.1.
- Instrumentation
- Basic signal source
The current industry standard relies on the magnetic field sensors of low-temperature superconducting quantum interference devices (SQUIDs) as the main sensors for measuring MEG signals. SQUIDs sensors use the principles of quantum physics to detect small currents, such as those caused by weak magnetic signals, with high sensitivity and large dynamic range.
In a magnetoencephalogram, electrochemical currents circulating inside and between neurons produce magnetic induction. post-synaptic potentials (PSPs) are considered to be the main source of these ionic currents.
Fig.1 Resting-state networks obtained with MEG imaging. (Baillet, 2017)
Applications of MEG
- Epilepsy
Magnetic brain imaging is used for the planning of epilepsy surgery. Through a multi-center prospective magnetoencephalogram prediction test, part of the intracranial explorations are guided by MEG source imaging, and then surgical resection, which has a significant inhibitory effect on patients' long-term seizure freedom after epilepsy surgery. Especially in the case of overtime lobe epilepsy and non-pathological changes, MEG provided excellent accuracy.
Fig.2 MEG location before and after surgery in patients with epilepsy. (Rampp, 2019)
- A new type of wearable system MEG
This new invention opens the door to neuroscience research. Compared with traditional MEG, research objects can move naturally and interact with the real world, as shown in Fig.3. The system opens up new possibilities for scanning any subject or group of patients, including applications, such as neurodevelopmental connector features, imaging subjects' natural movement in a virtual environment, and studying the pathophysiology of movement disorders.
Fig.3 Wearable MEG imaging paradigm of the subject while playing with a ball. (Boto, 2018)
MEG helps us to understand regional and large-scale brain dynamics more deeply: from the function of neural oscillations and related brain activation events to the functional connection mechanism between regions and the emergence of network communication patterns in the brain system. MEG is playing an increasingly critical role in elucidating the magnificent mechanical principles of cognition, the brain system, and clinical neuroscience.
Creative Biolabs has been focusing on neuroscience and neurological diseases research for many years. Our rich experience and reliable products can help you achieve the most efficient research in a shorter time. Our goal is to cooperate with customers to jointly promote the development of the neurological field.
References
- Baillet, S. Magnetoencephalography for brain electrophysiology and imaging. Nature neuroscience. 2017, 20(3): 327-339.
- Rampp, S.; et al. Magnetoencephalography for epileptic focus localization in a series of 1000 cases. Brain. 2019, 142(10): 3059-3071.
- Boto, E.; et al. Moving magnetoencephalography towards real-world applications with a wearable system. Nature. 2018, 555(7698): 657-661.
- NeuroMab™ Anti-F-Spondin/SPON1 Antibody, Clone N24875P (CBP11839) (Cat#: NRZP-0822-ZP4740)
- NeuroMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- NeuroMab™ Anti-GARP Antibody(NRP-0422-P1639) (Cat#: NRP-0422-P1639)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1684) (Cat#: NRP-0422-P1684)
- NeuroMab™ Anti-Alpha Synuclein BBB Shuttle Antibody(NRZP-1022-ZP4050) (Cat#: NRZP-1022-ZP4050)
- NeuroMab™ Anti-EPHB2 Antibody(NRP-0422-P1220) (Cat#: NRP-0422-P1220)
- NeuroMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- NeuroMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1760) (Cat#: NRP-0422-P1760)
- NeuroMab™ Anti-TREM2 BBB Shuttle Antibody(NRZP-1022-ZP4114) (Cat#: NRZP-1022-ZP4114)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Human Microglia Cell Line HMC3, Immortalized (Cat#: NCL-2108P38)
- iNeu™ Microglia (Cat#: NCL-7P018)
- Mouse Glioma Cell Line GL261-GFP (Cat#: NCL-2108P04)
- Human Brain Microvascular Endothelial Cells (Cat#: NCL-2103-P133)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Human Hippocampal Neuron Cells HPPNCs (Cat#: NCL2110P106)
- Human Glioblastoma Cell Line SF126 (Cat#: NCL-2108P35)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Dextran-CYanine5.5 (Cat#: NTA-2011-ZP118)
- Dextran, NHS Activated, 40 kDa (Cat#: NRZP-0722-ZP124)
- pAAV-syn-FLEX-jGCaMP8f-WPRE (Cat#: NTA-2106-P064)
- Dextran-FITC (Cat#: NTA-2011-ZP110)
- Dextran, Cy5 Labeled, 2000 kDa (Cat#: NRZP-0722-ZP22)
- pAAV-syn-jGCaMP8s-WPRE (Cat#: NTA-2106-P063)
- pAAV-syn-jGCaMP8m-WPRE (Cat#: NTA-2106-P062)
- PRV-CAG-EGFP (Cat#: NTA-2011-ZP14)
- AAV2/9-hSyn-Flpo-EGFP-WPRE-pA (Cat#: NTA-2012-ZP149)
- AAV2/9-hEF1a-DIO-mCherry-P2A-TetTox-WPRE-pA (Cat#: NTA-2012-ZP268)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)